Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts.

Thorax·2025
Same author

Ambient PM<sub>2.5</sub> exposure and tuberculosis reactivation: a cross-sectional study in an intermediate burden city.

Epidemiology and infection·2025
Same author

Assessment of the Psychometric Properties of the Mask Usability Scale: A Measure of the Perceived Usability of N95 Respirators Among Healthcare Students and Staff.

Journal of advanced nursing·2024
Same author

No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppression.

HIV medicine·2024
Same author

Association of smoking cessation with airflow obstruction in workers with silicosis: A cohort study.

PloS one·2024
Same author

Use of spirometry to detect airflow obstruction.

Respirology (Carlton, Vic.)·2024
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

シリコシスシリコシス

Chi Chiu Leung1, Ignatius Tak Sun Yu, Weihong Chen

  • 1Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China. cc_leung@dh.gov.hk

Lancet (London, England)
|April 27, 2012
PubMed
まとめ
この要約は機械生成です。

シリコシスは,シリカ粉を吸入した肺の線維性疾患で,進行的な肺機能障害を引き起こす. 治療法はないが,管理戦略は生活の質を向上させ,病気の進行を遅らせる.

さらに関連する動画

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

関連する実験動画

Last Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

科学分野:

  • 職業衛生は,健康に関するものです.
  • 肺内医学 肺内医学 肺内医学
  • 毒理学 毒理学 毒理学

背景:

  • シリコシスは,結晶のシリカを吸入することによって引き起こされる重度の線維性肺疾患です.
  • シリカ粉への職業的曝露は,多くの産業で一般的です.
  • シリカを吸入すると,炎症ゾームの活性化によって肺炎と線維症を引き起こします.

研究 の 目的:

  • シリコシスの病原性,診断,管理を要約する.
  • シリカエクスポージャーと他の深刻な肺疾患との関連を強調するために.
  • 危険性の認識と制御の改善の必要性を強調すること,特に開発途上国において.

主な方法:

  • シリコシス病原性に関する既存の文献のレビュー.
  • 診断基準の分析,職業歴および放射線学的発見を含む.
  • 現在の管理戦略と関連するリスクの検討.

主要な成果:

  • シリカを吸入すると,リソソーム損傷とNALP3炎症体の活性化が発生し,肺炎と線維症を引き起こします.
  • 肺機能障害は,曝露の停止後でも進行する.
  • 診断には,文書化された職業暴露と,他の条件を除く,特徴的な放射線学的特徴が必要です.

結論:

  • シリコシスは,患者の生活の質を改善し,病気の進行を遅らせるため,包括的な管理を必要とします.
  • 関連するリスクには,真菌菌疾患,呼吸道阻害,肺がんが含まれます.
  • 強化された世界的な取り組みは,特に開発途上国において,シリカガスの危険性の制御に不可欠です.